DK111392A - Antiviralt virksom farmaceutisk olie-i-vandemulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf - Google Patents

Antiviralt virksom farmaceutisk olie-i-vandemulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf Download PDF

Info

Publication number
DK111392A
DK111392A DK111392A DK111392A DK111392A DK 111392 A DK111392 A DK 111392A DK 111392 A DK111392 A DK 111392A DK 111392 A DK111392 A DK 111392A DK 111392 A DK111392 A DK 111392A
Authority
DK
Denmark
Prior art keywords
acyclovir
ester
salt
hydroxyethoxy
guanine
Prior art date
Application number
DK111392A
Other languages
English (en)
Other versions
DK111392D0 (da
DK169121B1 (da
Inventor
Knud Erik Gebhard-Hansen
S Ren Bols Pedersen
Rnsdottir Karen Bj
Bodil Gyllembourg Lissau
B Rge Ingvar Frisch Alhede
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Publication of DK111392D0 publication Critical patent/DK111392D0/da
Priority to DK111392A priority Critical patent/DK169121B1/da
Priority to HR1113/92A priority patent/HRP931160B1/xx
Priority to RO95-00478A priority patent/RO113306B1/ro
Priority to CZ95599A priority patent/CZ284007B6/cs
Priority to CA002142493A priority patent/CA2142493A1/en
Priority to BR9307024A priority patent/BR9307024A/pt
Priority to HU9500702A priority patent/HUT72606A/hu
Priority to SI9300469A priority patent/SI9300469A/sl
Priority to JP6506765A priority patent/JPH08501089A/ja
Priority to DE69302396T priority patent/DE69302396T2/de
Priority to LTIP959A priority patent/LT3056B/lt
Priority to PL93307860A priority patent/PL172663B1/pl
Priority to AU49453/93A priority patent/AU4945393A/en
Priority to PCT/DK1993/000288 priority patent/WO1994005258A1/en
Priority to UA95038210A priority patent/UA41897C2/uk
Priority to AT93919042T priority patent/ATE137113T1/de
Priority to ES93919042T priority patent/ES2086235T3/es
Priority to SK291-95A priority patent/SK280119B6/sk
Priority to EP93919042A priority patent/EP0662819B1/en
Priority to ZA936661A priority patent/ZA936661B/xx
Priority to RU95110930A priority patent/RU2128503C1/ru
Publication of DK111392A publication Critical patent/DK111392A/da
Priority to EE9400083A priority patent/EE03088B1/xx
Application granted granted Critical
Publication of DK169121B1 publication Critical patent/DK169121B1/da
Priority to FI951086A priority patent/FI112777B/fi
Priority to BG99484A priority patent/BG62032B1/bg
Priority to NO950895A priority patent/NO308234B1/no
Priority to LVP-95-90A priority patent/LV10912B/en
Priority to GR960401359T priority patent/GR3019984T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK111392A 1992-09-09 1992-09-09 Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf DK169121B1 (da)

Priority Applications (27)

Application Number Priority Date Filing Date Title
DK111392A DK169121B1 (da) 1992-09-09 1992-09-09 Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
HR1113/92A HRP931160B1 (en) 1992-09-09 1993-09-07 An antivirally active pharmaceutical oil-in-water emulsion containing 9-/(2-hydroxyethoxy)methyl/guanine (acyclovir) or a salt or ester thereof
UA95038210A UA41897C2 (uk) 1992-09-09 1993-09-09 Антивірусно-активна фармацевтична емульсія типу масло-у-воді, що містить 9-[(2-гідроксіетокси)метил]гуанін (ацикловір) або його сіль або ефір
AT93919042T ATE137113T1 (de) 1992-09-09 1993-09-09 Antiviral wirksame pharmazeutische öl in wasser- emulsion, die 9-((2-hydroxyethoxy)methyl>-guanin (acyclovir) oder ein salz oder einen ester davon enthält
CA002142493A CA2142493A1 (en) 1992-09-09 1993-09-09 An antivirally active pharmaceutical oil-in-water emulsion containing 9-¬(2-hydroxyethoxy)methyl|guanine (acyclovir) or a salt or ester thereof
BR9307024A BR9307024A (pt) 1992-09-09 1993-09-09 Emulsão óleo-em-água farmacéutica antiviroticamente ativa contendo 9-[2-hidroxietóxi)metil]guanina (aciclovir) ou um sal ou éster da mesma
HU9500702A HUT72606A (en) 1992-09-09 1993-09-09 An antivirally active pharmaceutical oil-in-water emulsion containing 9-[(2-hydroxyethoxy)-metyl]guanine(acyclovir) or salt or ester thereof
SI9300469A SI9300469A (en) 1992-09-09 1993-09-09 Antivirally active pharmaceutical oil-in-water emulsion containing 9-((2-hydroxyethoxy)methyl)guanine (acyclovir) or salt or ester thereof
JP6506765A JPH08501089A (ja) 1992-09-09 1993-09-09 ９−［（２−ヒドロキシエトキシ）メチルグアニン（アシクロヴィア）またはその塩もしくはエステルを含む抗ウイルス活性医薬水中油型エマルジョン
DE69302396T DE69302396T2 (de) 1992-09-09 1993-09-09 Antiviral wirksame pharmazeutische öl in wasser-emulsion, die 9-[(2-hydroxyethoxy)methyl]-guanin (acyclovir) oder ein salz oder einen ester davon enthält
LTIP959A LT3056B (en) 1992-09-09 1993-09-09 An antivirally active pharmaceutical oil-in-water emulsion containing 9-£(2-hydroxy-ethoxy)methyl|guanine (acyclovir) or a salt or ester thereof
PL93307860A PL172663B1 (pl) 1992-09-09 1993-09-09 hydroksyetoksy)metylo]guanine (acyklowir) lub sól albo ester tego zwiazku PL PL PL PL PL PL PL PL
AU49453/93A AU4945393A (en) 1992-09-09 1993-09-09 An antivirally active pharmaceutical oil-in-water emulsion containing 9-{(2-hydroxyethoxy)methyl}guanine (acyclovir) or a salt or ester thereof
PCT/DK1993/000288 WO1994005258A1 (en) 1992-09-09 1993-09-09 An antivirally active pharmaceutical oil-in-water emulsion containing 9-[(2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof
RO95-00478A RO113306B1 (ro) 1992-09-09 1993-09-09 Emulsie antivirala u/a
CZ95599A CZ284007B6 (cs) 1992-09-09 1993-09-09 Protivirově aktivní farmaceutická emulze oleje ve vodě obsahující 9-{(2-hydroxyethoxy)metyl}quanin (acyclovir) nebo jeho sole nebo estery
ES93919042T ES2086235T3 (es) 1992-09-09 1993-09-09 Emulsion farmaceutica de aceite en agua antiviricamente activa que contiene 9-((2-hidroxietoxi)metil)guanina (aciclovir) o una sal o ester del mismo.
SK291-95A SK280119B6 (sk) 1992-09-09 1993-09-09 Antivírusová aktívna farmaceutická emulzia
EP93919042A EP0662819B1 (en) 1992-09-09 1993-09-09 An antivirally active pharmaceutical oil-in-water emulsion containing 9-[(2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof
ZA936661A ZA936661B (en) 1992-09-09 1993-09-09 An antivirally active pharmaceutical oil-in-water emulsion containing 9-(2-hydroxyethoxy) methyl)guanine (acyclovir) or a salt or ester thereof
RU95110930A RU2128503C1 (ru) 1992-09-09 1993-09-09 Антивирусная фармацевтическая эмульсия типа масло в воде
EE9400083A EE03088B1 (et) 1992-09-09 1994-08-09 Viirusvastaselt aktiivne farmatseutiline õlivesiemulsioon, mis sisaldab 9-[(2-hüdroksüetoksü)metüül]guaniini (atsükloviiri) või selle soola või estrit
FI951086A FI112777B (fi) 1992-09-09 1995-03-08 Valmistusmenetelmä antivirus-aktiiviselle farmaseuttiselle öljy-vedessä emulsiolle, jossa on 9-[(2-hydroksietoksi)-metyyli]-guaniini (asyklovir) tai sen suola tai esteri
BG99484A BG62032B1 (bg) 1992-09-09 1995-03-08 Антивирусна активна фармацевтична емулсия от масло във вода,съдържаща ацикловир или негова сол, или естер
NO950895A NO308234B1 (no) 1992-09-09 1995-03-08 Farmasøytisk olje-i-vann-emulsjon med antivirusaktivitet inneholdende 9-[(2-hydroksyetoksy)-metyl]guanidin (acyclovir) eller et salt eller en ester derav
LVP-95-90A LV10912B (en) 1992-09-09 1995-04-07 An antivirally active pharmaceutical oil-in-water emulsion containing 9-£(2-hydroxyethoxy)methyl|guanine (acyclovir) or a salt or ester thereof
GR960401359T GR3019984T3 (en) 1992-09-09 1996-05-20 An antivirally active pharmaceutical oil-in-water emulsion containing 9- (2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK111392 1992-09-09
DK111392A DK169121B1 (da) 1992-09-09 1992-09-09 Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf

Publications (3)

Publication Number Publication Date
DK111392D0 DK111392D0 (da) 1992-09-09
DK111392A true DK111392A (da) 1994-03-10
DK169121B1 DK169121B1 (da) 1994-08-22

Family

ID=8101156

Family Applications (1)

Application Number Title Priority Date Filing Date
DK111392A DK169121B1 (da) 1992-09-09 1992-09-09 Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf

Country Status (27)

Country Link
EP (1) EP0662819B1 (da)
JP (1) JPH08501089A (da)
AT (1) ATE137113T1 (da)
AU (1) AU4945393A (da)
BG (1) BG62032B1 (da)
BR (1) BR9307024A (da)
CA (1) CA2142493A1 (da)
CZ (1) CZ284007B6 (da)
DE (1) DE69302396T2 (da)
DK (1) DK169121B1 (da)
EE (1) EE03088B1 (da)
ES (1) ES2086235T3 (da)
FI (1) FI112777B (da)
GR (1) GR3019984T3 (da)
HR (1) HRP931160B1 (da)
HU (1) HUT72606A (da)
LT (1) LT3056B (da)
LV (1) LV10912B (da)
NO (1) NO308234B1 (da)
PL (1) PL172663B1 (da)
RO (1) RO113306B1 (da)
RU (1) RU2128503C1 (da)
SI (1) SI9300469A (da)
SK (1) SK280119B6 (da)
UA (1) UA41897C2 (da)
WO (1) WO1994005258A1 (da)
ZA (1) ZA936661B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4416674C2 (de) * 1994-05-11 1997-01-30 Rentschler Arzneimittel Topische Zubereitung enthaltend Aciclovir
ZA96525B (en) * 1995-02-06 1996-08-06 Astra Ab Novel pharmaceutical compositions
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
FR2753626B1 (fr) * 1996-09-20 1998-11-06 Centre International De Rech Dermatologiques Galderma Cird Galderma Nouvelles compositions topiques sous forme d'emulsion fluide h/e a forte teneur en glycol pro-penetrant
AU2004202929B2 (en) * 1999-09-22 2006-11-23 B. Ron Johnson Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
WO2005067941A1 (es) * 2004-01-08 2005-07-28 Universidad De Concepcion Formulacion topica de aciclovir
JP2007532697A (ja) * 2004-04-19 2007-11-15 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー 局所的血流増大の有益な効果
US20050257718A1 (en) * 2004-05-22 2005-11-24 Engelhard Corporation Natural Pearl in Butylene Glycol
WO2007121318A2 (en) * 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Formulations for delivering insulin
WO2008006085A2 (en) * 2006-07-07 2008-01-10 University Of Washington Compositions and methods for predicting inhibitors of protein targets
CN102481275B (zh) 2009-06-24 2014-07-23 战略科学技术有限公司 含有布洛芬的表面组合物
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
EP2658551B1 (en) 2010-12-29 2020-07-01 Strategic Science & Technologies, LLC Treatment of erectile dysfunction and other indications
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
FR3023718B1 (fr) * 2014-07-16 2018-10-12 Pierre Fabre Medicament Compositions pharmaceutique et/ou cosmetique decontaminees par haute pression
GB201819418D0 (en) 2018-11-29 2019-01-16 Daniel Calladine Ltd Anti-viral compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations

Also Published As

Publication number Publication date
RU2128503C1 (ru) 1999-04-10
LV10912B (en) 1996-08-20
EP0662819A1 (en) 1995-07-19
HRP931160A2 (en) 1995-12-31
BR9307024A (pt) 1999-06-29
LTIP959A (en) 1994-05-15
SK280119B6 (sk) 1999-08-06
NO950895D0 (no) 1995-03-08
GR3019984T3 (en) 1996-08-31
DK111392D0 (da) 1992-09-09
CZ284007B6 (cs) 1998-07-15
NO308234B1 (no) 2000-08-21
UA41897C2 (uk) 2001-10-15
DE69302396D1 (de) 1996-05-30
PL307860A1 (en) 1995-06-26
FI112777B (fi) 2004-01-15
NO950895L (no) 1995-03-08
PL172663B1 (pl) 1997-10-31
LV10912A (lv) 1995-12-20
LT3056B (en) 1994-10-25
HU9500702D0 (en) 1995-04-28
FI951086A7 (fi) 1995-03-08
HUT72606A (en) 1996-05-28
ATE137113T1 (de) 1996-05-15
BG99484A (bg) 1995-12-29
DE69302396T2 (de) 1996-08-14
ES2086235T3 (es) 1996-06-16
DK169121B1 (da) 1994-08-22
WO1994005258A1 (en) 1994-03-17
SI9300469A (en) 1994-03-31
JPH08501089A (ja) 1996-02-06
AU4945393A (en) 1994-03-29
EE03088B1 (et) 1998-06-15
EP0662819B1 (en) 1996-04-24
RO113306B1 (ro) 1998-06-30
ZA936661B (en) 1994-05-20
SK29195A3 (en) 1997-01-08
RU95110930A (ru) 1997-03-27
CA2142493A1 (en) 1994-03-17
FI951086A0 (fi) 1995-03-08
BG62032B1 (bg) 1999-01-29
CZ59995A3 (en) 1995-09-13
HRP931160B1 (en) 1999-04-30

Similar Documents

Publication Publication Date Title
DK111392D0 (da) Antiviralt virksom farmaceutisk olie-i-vandemulsion indeholdende 9-oe(2-hydroxyethoxy)methylaaguanin (acyclovir) eller et salt eller en ester deraf.
US4963555A (en) Formulations of heterocyclic compounds
KR920021139A (ko) 약학 조성물
IE811617L (en) Topical formulations of 9-(2-hydroxyethoxymethyl) guanine
FR2706298B1 (fr) Composition cosmétique ou dermatologique sous forme d'une émulsion huile-dans-l'eau stable contenant au moins une huile végétale constituée d'au moins 40% de triglycérides d'acide linoléique.
CA2074503C (en) Pharmaceutical formulation containing penciclovir
EP0593562B1 (en) Topical composition containing penciclovir
CA2022632A1 (en) Pharmaceutical formulation
KR890014087A (ko) 오일이 함유된 투명화장수의 제조방법
HK1012242B (en) Topical composition containing penciclovir

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK